Early screening to prevent preeclampsia and save money: A win-win
Cost-effectiveness analysis of a model of first-trimester prediction and prevention of preterm pre-eclampsia compared with usual care
This Australian-based study examined the potential health outcomes and cost implications following the introduction of a first-trimester intervention screening for preterm preeclampsia, comparing it to usual care, in 6822 women between 2015-2016. “Usual care” consisted of women being initially screened by general practitioners, and initiation of aspirin 100 mg daily from 12 weeks’ of pregnancy until delivery in those deemed to be high-risk. The study intervention added biomarkers to screening for aneuploidy (baby having one or more extra or missing chromosomes) at the 11-13 weeks prenatal visit. Women then deemed high-risk were immediately prescribed aspirin 150mg daily until 36 weeks’ gestation. The intervention resulted in 31 fewer cases of preeclampsia and lower health costs ($1,431,186 Australian dollars) over the study period.
Take home message: This study shows strong evidence for first-trimester prediction and prevention of preterm preeclampsia that could be considered for guideline recommendations. Application of this screening in a large, modern US research cohort would provide even more evidence to support this strategy in clinical implementation.
Link: https://pubmed.ncbi.nlm.nih.gov/32851709/
About Research Roundup
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, MD Jenny Sones, PhD, DVM, and Robin Trupp, PhD, RN.
Related Articles
By Amanda Yang, MS Evidence-based healthcare comes from trustworthy research. Research is designed carefully, so that it can be repeated and tested by other scientists. Wrong information or bad data...
By Sig-Linda Jacobsen, MD Neurological symptoms are not uncommon in those who have preeclampsia. The most common symptom is severe headache. Some patients may also experience eclampsia, or seizu...
Summary by Jennifer Mitchell, MPH, PhD Preeclampsia is a serious condition that can happen during pregnancy and affects 2-8% of pregnancies around the world. It can cause health problems for both the...
By Julie Reynolds, MD and Laney Poye As the Foundation often shares, research shows that women with a history of preeclampsia are two to four times more likely to develop cardiovascular disease (CVD)...
Genetic predictors of blood pressure traits are associated with preeclampsia Although underlying causes of preeclampsia are not fully understood, there is evidence suggesting a strong genetic compone...